Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery

References

• Brown PA, Shah B, Fathi A, Wieduwilt M, Advani A, Aoun P, Barta SK, Boyer MW, Bryan T, Burke PW, et al. NCCN guidelines insights: Acute lymphoblastic leukemia, version 1.2017. J Natl Comprehensive Cancer Network: JNCCN. 2017;15:1091–102. doi:10.6004/jnccn.2017.0147.
   PubMed Web of Science ®Google Scholar
• Fan M, Li M, Gao L, Geng S, Wang J, Wang Y, Yan Z, Yu L. Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia. J Hematol Oncol. 2017;10:151. doi:10.1186/s13045-017-0519-7.
   PubMed Web of Science ®Google Scholar
• Lai Y, Weng J, Wei X, Qin L, Lai P, Zhao R, Jiang Z, Li B, Lin S, Wang S, et al. Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T cells. Leukemia. 2018;32:801–806. doi: 10.1038/ leu.2017.249.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kong Y, Zhang J, Claxton DF, Ehmann WC, Rybka WB, Palmisiano ND, Wang M, Jia B, Bayerl M, et al. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia. J Hematol Oncol. 2017;10:124. doi:10.1186/s13045-017-0486-z.
   PubMed Web of Science ®Google Scholar
• Ni X, Song Q, Cassady K, Deng R, Jin H, Zhang M, Dong H, Forman S, Martin PJ, Chen YZ, et al. PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells. J Clin Invest. 2017;127:1960–77. doi:10.1172/JCI91138.
   PubMed Web of Science ®Google Scholar
• Tsai HF, Hsu PN. Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets. J Biomed Sci. 2017;24:35. doi:10.1186/s12929-017-0341-0.
   PubMed Web of Science ®Google Scholar
• Bachireddy P, Hainz U, Rooney M, Pozdnyakova O, Aldridge J, Zhang W, Liao X, Hodi FS, O'Connell K, Haining WN, et al. Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. Blood. 2014;123:1412–21. doi:10.1182/blood-2013-08-523001.
   PubMed Web of Science ®Google Scholar
• Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F, et al. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol. 2014;15:69–77. doi:10.1016/S1470-2045(13)70551-5.
   PubMed Web of Science ®Google Scholar
• Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, Khan O, Drake AM, Chen Z, Sen DR, Kurachi M, et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science (New York, NY). 2016;354:1160–5. doi:10.1126/science.aaf2807.
   Google Scholar
• Sen DR, Kaminski J, Barnitz RA, Kurachi M, Gerdemann U, Yates KB, Tsao HW, Godec J, LaFleur MW, Brown FD, et al. The epigenetic landscape of T cell exhaustion. Science (New York, NY). 2016;354:1165–9. doi:10.1126/science.aae0491.
   Google Scholar
• Hisada Y, Mackman N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood. 2017;130:1499–1506. doi:10.1182/blood-2017-03-743211.
   PubMed Web of Science ®Google Scholar
• Menck K, Bleckmann A, Wachter A, Hennies B, Ries L, Schulz M, Balkenhol M, Pukrop T, Schatlo B, Rost U, et al. Characterisation of tumour-derived microvesicles in cancer patients' blood and correlation with clinical outcome. J Extracellular Vesicles. 2017;6:1340745. doi:10.1080/20013078.2017.1340745.
   PubMed Web of Science ®Google Scholar
• Zhu X, You Y, Li Q, Zeng C, Fu F, Guo A, Zhang H, Zou P, Zhong Z, Wang H, et al. BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia. Leukemia. 2014;28:1666–75. doi:10.1038/leu.2014.51.
   PubMed Web of Science ®Google Scholar
• Berchem G, Noman MZ, Bosseler M, Paggetti J, Baconnais S, Le Cam E, Nanbakhsh A, Moussay E, Mami-Chouaib F, Janji B, et al. Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-beta and miR23 a transfer. Oncoimmunology. 2016;5:e1062968. doi:10.1080/2162402X.2015.1062968.
   PubMed Web of Science ®Google Scholar
• Zhang HM, Li Q, Zhu X, Liu W, Hu H, Liu T, Cheng F, You Y, Zhong Z, Zou P, et al. miR-146b-5p within BCR-ABL1-positive microvesicles promotes leukemic transformation of hematopoietic cells. Cancer Res. 2016;76:2901–11. doi:10.1158/0008-5472.CAN-15-2120.
   PubMed Web of Science ®Google Scholar
• Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, Freeman GJ, Kuchroo VK, Ahmed R. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 2010;107:14733–8. doi:10.1073/pnas.1009731107.
   PubMed Web of Science ®Google Scholar
• Krishna S, Xie D, Gorentla B, Shin J, Gao J, Zhong XP. Chronic activation of the kinase IKKbeta impairs T cell function and survival. J Immunol (Baltimore, Md: 1950). 2012;189:1209–19. doi:10.4049/jimmunol.1102429.
   PubMed Web of Science ®Google Scholar
• Terao M, Fratelli M, Kurosaki M, Zanetti A, Guarnaccia V, Paroni G, Tsykin A, Lupi M, Gianni M, Goodall GJ, et al. Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem. 2011;286:4027–42. doi:10.1074/jbc.M110.184994.
   PubMed Web of Science ®Google Scholar
• Bally AP, Lu P, Tang Y, Austin JW, Scharer CD, Ahmed R, Boss JM. NF-kappaB regulates PD-1 expression in macrophages. J Immunol (Baltimore, Md: 1950). 2015;194:4545–54. doi:10.4049/jimmunol.1402550.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang CC, Jin L, Zhang XD. Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Annals Oncol Official J Eur Soc Medical Oncol. 2016;27:409–16. doi:10.1093/annonc/mdv615.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang W, Liu C, Lu J, Sun K. Role of NF-kappaB/GATA3 in the inhibition of lysyl oxidase by IL-1beta in human amnion fibroblasts. Immunol Cell Biol. 2017;95:943–52. doi:10.1038/icb.2017.73.
   PubMed Web of Science ®Google Scholar
• Delhase M, Kim SY, Lee H, Naiki-Ito A, Chen Y, Ahn ER, Murata K, Kim SJ, Lautsch N, Kobayashi KS, et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci U S A. 2012;109:E177–86. doi:10.1073/pnas.1119296109.
   PubMed Web of Science ®Google Scholar
• Abramowski-Mock U, Delhove JM, Qasim W. Gene modified T cell therapies for hematological malignancies. Hematol /Oncol Clin N Am. 2017;31:913–26. doi:10.1016/j.hoc.2017.06.005.
   PubMed Web of Science ®Google Scholar
• Ozkazanc D, Yoyen-Ermis D, Tavukcuoglu E, Buyukasik Y, Esendagli G. Functional exhaustion of CD4+ T cells induced by co-stimulatory signals from myeloid leukaemia cells. Immunology. 2016;149:460–71. doi:10.1111/imm.12665.
   PubMed Web of Science ®Google Scholar
• Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, et al. Oncolytic virotherapy promotes Intratumoral T cell infiltration and improves Anti-PD-1 immunotherapy. Cell. 2017;170:1109–19.e10. doi:10.1016/j.cell.2017.08.027.
   PubMed Web of Science ®Google Scholar
• Alsaab HO, Sau S, Alzhrani R, Tatiparti K, Bhise K, Kashaw SK, Iyer AK. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: Mechanism, combinations, and clinical outcome. Frontiers Pharmacol. 2017;8:561. doi:10.3389/fphar.2017.00561.
   PubMed Web of Science ®Google Scholar
• Scott-Browne JP, Lopez-Moyado IF, Trifari S, Wong V, Chavez L, Rao A, Pereira RM. Dynamic changes in chromatin accessibility occur in CD8+ T cells responding to viral infection. Immunity. 2016;45:1327–40. doi:10.1016/j.immuni.2016.10.028.
   PubMed Web of Science ®Google Scholar
• Ghoneim HE, Fan Y, Moustaki A, Abdelsamed HA, Dash P, Dogra P, Carter R, Awad W, Neale G, Thomas PG, et al. De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell. 2017;170:142–57.e19. doi:10.1016/j.cell.2017.06.007.
   PubMed Web of Science ®Google Scholar
• Wang R, Xu A, Zhang X, Wu J, Freywald A, Xu J, Xiang J. Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40 L signaling through the mTORC1 pathway. Cell Mol Immunol. 2017;14:529–45. doi:10.1038/cmi.2016.23.
   PubMed Web of Science ®Google Scholar
• Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res. 2011;1:98–110
   PubMed Web of Science ®Google Scholar
• da Silveira JC, de Avila A, Garrett HL, Bruemmer J, Winger Q, Bouma G. Cell-secreted vesicles containing microRNAs as regulators of gamete maturation. J Endocrinol. 2018;236:R15–R27. doi:10.1530/JOE-17-0200.
   PubMed Web of Science ®Google Scholar
• Zhang G, Li N, Li Z, Zhu Q, Li F, Yang C, Han Q, Lv Y, Zhou Z, Liu Z. microRNA-4717 differentially interacts with its polymorphic target in the PD1 3' untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases. Oncotarget. 2015;6:18933–44
   PubMedGoogle Scholar
• Ghandadi M, Sahebkar A. MicroRNA-34 a and its target genes: Key factors in cancer multidrug resistance. Curr Pharmaceutical Design. 2016;22:933–9. doi:10.2174/1381612822666151209153729.
   PubMed Web of Science ®Google Scholar
• Li Q, Johnston N, Zheng X, Wang H, Zhang X, Gao D, Min W. miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion. Oncotarget. 2016;7:53735–50
   PubMedGoogle Scholar
• Bally AP, Tang Y, Lee JT, Barwick BG, Martinez R, Evavold BD, Boss JM. Conserved region C functions to regulate PD-1 expression and subsequent CD8 T cell memory. J Immunol (Baltimore, Md: 1950) 2017;198:205–17. doi:10.4049/jimmunol.1601464.
   Google Scholar
• Zhao A, Yang Z, Sun R, Grinchuk V, Netzel-Arnett S, Anglin IE, Driesbaugh KH, Notari L, Bohl JA, Madden KB, et al. SerpinB2 is critical to Th2 immunity against enteric nematode infection. J Immunol (Baltimore, Md: 1950). 2013;190:5779–87. doi:10.4049/jimmunol.1200293.
   PubMed Web of Science ®Google Scholar
• Sharfe N, Merico D, Karanxha A, Macdonald C, Dadi H, Ngan B, Herbrick JA, Roifman CM. The effects of RelB deficiency on lymphocyte development and function. J Autoimmunity. 2015;65:90–100. doi:10.1016/j.jaut.2015.09.001.
   PubMed Web of Science ®Google Scholar
• Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25. doi:10.1186/gb-2009-10-3-r25.
   PubMed Web of Science ®Google Scholar
• Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357–60. doi:10.1038/nmeth.3317.
   PubMed Web of Science ®Google Scholar
• Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. doi:10.1186/1471-2105-12-323.
   PubMed Web of Science ®Google Scholar
• Tarazona S, Furio-Tari P, Turra D, Pietro AD, Nueda MJ, Ferrer A, Conesa A. Data quality aware analysis of differential expression in RNA-seq with NOISeq R/Bioc package. Nucleic Acids Res. 2015;43:e140
   PubMed Web of Science ®Google Scholar
• Zhang HM, Liu T, Liu CJ, Song S, Zhang X, Liu W, Jia H, Xue Y, Guo AY. AnimalTFDB 2.0: a resource for expression, prediction and functional study of animal transcription factors. Nucleic Acids Res. 2015;43:D76–81. doi:10.1093/nar/gku887.
   PubMed Web of Science ®Google Scholar
• Zhang HM, Kuang S, Xiong X, Gao T, Liu C, Guo AY. Transcription factor and microRNA co-regulatory loops: important regulatory motifs in biological processes and diseases. Briefings Bioinformatics. 2015;16:45–58. doi:10.1093/bib/bbt085.
   PubMed Web of Science ®Google Scholar
• Kohl M, Wiese S, Warscheid B. Cytoscape: software for visualization and analysis of biological networks. Methods Mol Biol (Clifton, NJ). 2011;696:291–303. doi:10.1007/978-1-60761-987-1_18.
   PubMedGoogle Scholar
• Ito K, Murphy D. Application of ggplot2 to Pharmacometric Graphics. CPT: Pharmacometrics Sys Pharmacol. 2013;2:e79
   PubMedGoogle Scholar
• Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3. doi:10.1186/gb-2003-4-5-p3.
   PubMed Web of Science ®Google Scholar